心臟房间分流装置市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球心房分流装置市场价值为 38 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 7%。该程序有助于调节血流和缓解压力不平衡，特别是对于患有某些心血管疾病的患者。透过优化血流，这些设备可以提高心臟效率并改善心臟相关问题患者的生活品质。

心臟房间分流装置的需求不断增加，很大程度上是由于医疗技术的不断进步所推动的。製造商不断改进设备设计，利用更好的材料，改进植入技术，以实现更安全、更有效的治疗。这些创新提高了设备性能，最终增强了医生信心并提高了采用率。随着支持使用这些设备的临床证据不断增加，市场潜力仍然广阔，特别是对于患有心臟衰竭和肺动脉高压等疾病的患者。

心房间分流装置市场的产品类型主要分为球囊扩张装置、自扩张装置和其他装置。其中，球囊扩张装置占据市场主导地位，预计 2024 年的收入份额为 21 亿美元。人们期待它们继续取得成功，因为它们在治疗一系列心臟疾病方面仍然非常有效，并且在未来几年显示出巨大的成长潜力。

在应用方面，市场中最大的份额属于心臟衰竭管理，到 2024 年将占据约 68.9% 的市场份额。心臟房间分流装置透过降低左心房压力和改善 HFpEF 患者的症状在这一领域发挥着至关重要的作用。此功能解决了心臟衰竭护理中尚未满足的重大需求，使这些设备成为现代心臟治疗的宝贵工具。

在美国，心臟房间分流装置市场规模将在 2024 年达到 11 亿美元，并有望显着成长。美国凭藉其先进的医疗基础设施、较高的心血管疾病发病率以及蓬勃发展的研发部门，在该市场处于领先地位。这些因素，加上对医疗技术的大量投入，加速了医院对心臟房间分流装置的创新和广泛使用，促进了市场在全国范围内的扩张。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 心臟衰竭盛行率上升
    • 技术进步
    • 微创手术的采用日益广泛
    • 老年人口基数不断扩大
  • 产业陷阱与挑战
    • 替代疗法的可用性
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 重要新闻和倡议
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品类型，2021 年至 2034 年

• 主要趋势
• 球囊扩张装置
• 自膨胀装置
• 其他产品类型

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 心臟衰竭管理
• 肺动脉高压治疗
• 其他应用

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 专科诊所
• 其他最终用途

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• Adona Medical
• Alleviant Medical
• BioVentrix
• Corvia Medical
• CryoLife
• Edwards Lifesciences
• Gore Medical
• InterShunt Technologies
• Johnson & Johnson
• Lepu Medical
• Medtronic
• Micro Interventional Devices
• Occlutech
• Venus Medtech
• Wuhan Weike Medical Technology

The Global Interatrial Shunt Devices Market was valued at USD 3.8 billion in 2024 and is set to grow at a CAGR of 7% from 2025 to 2034. Interatrial shunt devices are innovative medical technologies designed to create a controlled passage between the heart's left and right atria. This procedure helps regulate blood flow and alleviate pressure imbalances, particularly in patients suffering from certain cardiovascular conditions. By optimizing blood flow, these devices can enhance cardiac efficiency and improve the quality of life for individuals with heart-related issues.

The increasing demand for interatrial shunt devices is largely driven by the ongoing advancements in medical technology. Manufacturers are continuously improving device designs, utilizing better materials, and refining implantation techniques, which have led to safer and more effective treatments. These innovations have translated into enhanced device performance, ultimately boosting physician confidence and driving higher adoption rates. As clinical evidence supporting the use of these devices continues to grow, the market's potential remains expansive, particularly for patients with conditions like heart failure and pulmonary hypertension.

Product types in the interatrial shunt devices market are mainly categorized into balloon-expandable devices, self-expanding devices, and others. Among these, balloon-expandable devices are leading the market with an estimated revenue share of USD 2.1 billion in 2024. This segment's dominance is attributed to the devices' ease of deployment, precise positioning, and overall clinical advantages. Their continued success is expected, as they remain highly effective in treating a range of heart conditions and demonstrate significant growth potential in the coming years.

In terms of applications, the largest share of the market belongs to heart failure management, accounting for approximately 68.9% of the market in 2024. This segment is anticipated to continue its upward trajectory, fueled by the increasing prevalence of heart failure with preserved ejection fraction (HFpEF). Interatrial shunt devices play a crucial role in this area by reducing left atrial pressure and improving symptoms in HFpEF patients. This functionality addresses a significant unmet need in heart failure care, making these devices a valuable tool in modern cardiac treatments.

In the United States, the interatrial shunt devices market reached USD 1.1 billion in 2024 and is poised for notable growth. The U.S. stands as a leader in this market due to its advanced healthcare infrastructure, high incidence of cardiovascular diseases, and a thriving research and development sector. These factors, combined with substantial investments in medical technologies, have accelerated the innovation and widespread use of interatrial shunt devices in hospitals, contributing to the market's expansion across the country.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of heart failure
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Growing adoption of minimally invasive procedures
    • 3.2.1.4 Expanding geriatric population base
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of alternative treatments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Key news and initiatives
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Balloon expandable devices
• 5.3 Self-expanding devices
• 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Heart failure management
• 6.3 Pulmonary hypertension treatment
• 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Specialty clinics
• 7.5 Other End Use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Adona Medical
• 9.2 Alleviant Medical
• 9.3 BioVentrix
• 9.4 Corvia Medical
• 9.5 CryoLife
• 9.6 Edwards Lifesciences
• 9.7 Gore Medical
• 9.8 InterShunt Technologies
• 9.9 Johnson & Johnson
• 9.10 Lepu Medical
• 9.11 Medtronic
• 9.12 Micro Interventional Devices
• 9.13 Occlutech
• 9.14 Venus Medtech
• 9.15 Wuhan Weike Medical Technology